| Susan Kay Oppliger, PHYSICAL THERAPIST | |
|
Landstuhl Regional Medical Center, Attn:mceul-dccs (credentials), Apo, AE 09180 | |
| (011) 496-78366710 | |
| Not Available |
| Full Name | Susan Kay Oppliger |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | Landstuhl Regional Medical Center, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063470185 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 574 (Nebraska) | Secondary |
| 225100000X | Physical Therapist | 688 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susan Kay Oppliger, PHYSICAL THERAPIST Cmr 405, Box 1350, Apo, AE 09034 Ph: () - | Susan Kay Oppliger, PHYSICAL THERAPIST Landstuhl Regional Medical Center, Attn:mceul-dccs (credentials), Apo, AE 09180 Ph: (011) 496-78366710 |
News Archive
In a paper featured in Proceedings of the National Academy of Science (PNAS), researchers from Boston University School of Dental Medicine report the discovery of a new gene, STAT6(B), that helps regulate production of the potentially deadly tumor necrosis factor alpha (TNF-alpha) cytokine.
PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the University of Medicine & Dentistry of New Jersey (UMDNJ) in conjunction with the Company has commenced the screening of patients with End Stage Liver Disease (ESLD) for use in its clinical trial of UMK-121.
The study comprised over 24,000 Finnish subjects and was led by Professor Samuli Ripatti. The results revealed that a panel of 28 genetic markers improved detection of individuals with high risk for coronary heart disease (10-year risk ≥20%) over traditional risk factors.
Findings, published today [15 Jul] in Nature Communications, reveal the extent a mutation associated with autism and epilepsy plays in impairing a biochemical process in the brain. The study, led by University of Bristol researchers, could provide a new target for treating neurological disorders.
The human lymphatic system is an important but poorly understood circulatory system consisting of tiny vessels spread throughout the body.
› Verified 4 days ago
Joseph Frjelich, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112 Phone: 314-590-2368 | |
Emily Ward, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Usahc Vicenza, Apo, AE 09630 Phone: 339-619-7896 | |
Jenna Marie Boyd, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 3215, Apo, AE 09094 Phone: 314-479-2609 | |
Dr. Ashlyn Owens Hull, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: U.s. Army Health Clinic Hohenfels Unit 28216 Hohenfels,, Apo, AE 09173 Phone: 314-590-3300 | |
Maria Lebron, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Psc 94, Apo, AE 09824 Phone: 011-903-163223380 | |
Dr. Nicoleta Grigoras, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-8298 |